Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Osteoarthritis Cartilage ; 17(7): 832-42, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19217805

RESUMEN

OBJECTIVE: Compare the expression and regulation of nuclear receptors (NRs) in osteoarthritic and normal human articular cartilage. METHOD: The transcriptional levels of 48 NRs and additional related proteins were measured in mRNA from human articular cartilage from subjects with osteoarthritis (OA) and compared to samples from subjects without OA, using microarrays, individual quantitative reverse transcriptase polymerase chain reaction assays, and a custom human NR TaqMan Low Density Array (TLDA). The functional effect of liver X receptor (LXR) activity in cartilage was studied by measuring proteoglycan (PG) synthesis and degradation in articular cartilage explant cultures following treatment with the synthetic LXR agonist T0901317. RESULTS: Thirty-one of 48 NRs analyzed by TLDA were found to be measurably expressed in human articular cartilage; 23 of these 31 NRs showed significantly altered expression in OA vs unaffected cartilage. Among these, LXRalpha and LXRbeta, and their heterodimeric partners retinoid X receptor (RXR)alpha and RXRbeta were all expressed at significantly lower levels in OA cartilage, as were LXR target genes ABCG1 and apolipoproteins D and E. Addition of LXR agonist to human OA articular chondrocytes and to cartilage explant cultures resulted in activation of LXR-mediated transcription and significant reduction of both basal and interleukin (IL)-1-mediated PG degradation. CONCLUSIONS: Articular cartilage expresses a substantial number of NRs, and a large proportion of the expressed NRs are dysregulated in OA. In particular, LXR signaling in OA articular cartilage is impaired, and stimulation of LXR transcriptional activity can counteract the catabolic effects of IL-1. We conclude that LXR agonism may be a possible therapeutic option for OA.


Asunto(s)
Cartílago Articular/metabolismo , Proteínas de Unión al ADN/metabolismo , Osteoartritis/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Adulto , Anciano , Citocinas/farmacología , ADN Complementario/metabolismo , Proteínas de Unión al ADN/agonistas , Humanos , Hidrocarburos Fluorados/farmacología , Receptores X del Hígado , Persona de Mediana Edad , Receptores Nucleares Huérfanos , Proteoglicanos/metabolismo , Receptores Citoplasmáticos y Nucleares/agonistas , Receptores X Retinoide/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sulfonamidas/farmacología , Transcripción Genética/efectos de los fármacos
2.
Mech Dev ; 102(1-2): 223-6, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11287197

RESUMEN

We have isolated a new chicken gene that is a member of the cysteine-rich secreted protein family (CRISP). The CRISP family is composed of over 70 members that are found in many phyla of organisms, including: vertebrates, plants, fungi, yeast, and insects. Here we describe the cloning of a novel member of this family, SugarCrisp, and its expression pattern throughout chicken embryogenesis. We also describe its utility as a marker of thyroid and pancreatic mesoderm in the developing chicken embryo and its expression within the human and mouse in glandular tissue.


Asunto(s)
Proteínas Aviares , Cisteína/química , Mesodermo/metabolismo , Páncreas/embriología , Biosíntesis de Proteínas , Proteínas/química , Glándula Tiroides/embriología , Secuencia de Aminoácidos , Animales , Embrión de Pollo , Clonación Molecular , ADN Complementario/metabolismo , Embrión no Mamífero/metabolismo , Humanos , Hibridación in Situ , Pulmón/embriología , Datos de Secuencia Molecular , Proteínas/metabolismo , Homología de Secuencia de Aminoácido , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA